TABLE 1.
Envisioned application | Biopolymers and construct | Embedded phage | Relevant results |
Reference | |||
Study type | Phage release | Protective properties | Antimicrobial effects | ||||
Intestinal phage delivery | Millimeter sized beads with sodium alginate and chitosan core/shell structure. Alginate core viscosity was increased by supplementation with honey/gelatin. | E. coli phage ZSEC5 | In vitro | Complete phage release in 5 h under SIF conditions. | Resisted acidic environments (pH = 2) for 60 min and 3-min exposure to 80°C, both with a 1log10 reduction of embedded PFU. | 4.5–5log10 reduction of E. coli CFU after 10 h incubation. | Abdelsattar et al., 2019 |
Intestinal phage delivery | Microspheres of sodium alginate and chitosan core/shell structure. | E. coli phage O157:H7 | In vitro | 65% of embedded phage released after 6 h under SIF conditions. | Resisted acidic environments (pH = 2) for 60 min, with a 1.5log10 reduction of embedded PFU. | After 5 h incubation a 2.5log10 CFU reduction was observed compared to control cultures. | Kim et al., 2015 |
Intestinal phage delivery | Beads of Sodium Alginate with either a chitosan or a polyethyleneimine (PEI) coating | E. coli phage T4 | In vitro | Release plateaus after 12 h under SIF conditions. Chitosan and PEI coatings delayed phage release but reduced cumulative release as well. | Polycationic coatings increased acid resistance of embedded phage. 4log10 reduction in Alginate beads vs. 1log10 reduction in Alginate-PEI beads. | Not assessed | Moghtader et al., 2017 |
Preservation of meat | Sodium Alginate thin films | Pseudomonas fluorescens phage ϕIBB-PF7A | In vitro | Complete release of phage in 3 h. | PFU count was reduced by 4.2log10 after storage of 12 weeks at 4°C. | P. fluorescens CFU was reduced by 2log10 compared to control cultures. | Alves et al., 2019 |
Phage delivery for non-topical infections | Fibrin glue (TISSEEL®, Baxter, United States) | P. aeruginosa phage PA01 | In vitro | Phage release was followed for 11 days, in which daily release was between 109 and 1010 PFU/day. | Not assessed | Significant reductions in OD600 indicate antimicrobial effects, | Rubalskii et al., 2019 |
Treatment of cystic fibrosis | Spray dried or lyophilized particles of a mixture of trehalose, mannitol and leucine | P. aeruginosa phage PEV2 | In vitro | Phage delivery was in the order of 105 PFU per dose from an inhaler device. | Not assessed | Not assessed | Leung et al., 2016 |
Intestinal phage delivery | Sodium alginate and chitosan beads (±800 μm diameter) | Salmonellla phage Felix O1 | In vitro | Near complete phage release (1.6⋅107 PFU) in 5 h under SIF conditions. | After 60 min in SGF (pH = 2.4) a 2.6log10 reduction in phage titer was observed. At pH = 2, no titer was observed after 30 min. | Not assessed | Ma et al., 2008 |
Study type | Phage release | Protective properties | Antimicrobial effects | ||||
Intestinal phage delivery | Sodium Alginate/CaCO3– beads (±150 μm diameter) | Salmonella phages UAB_Phi20/Phi78/Phi87 | In vivo | 80–100% of all three phages were released after 40 min in SIF. | Titer loss after 60 min exposure to SGF approximately 2–3log10 for UAB_Phi78 and UAB_Phi87. No significant titer loss for UAB_Phi20. | Alginate/CaCO3– beads showed 1.7log10 reduction of excremental Salmonella. Effect of free phage was initially stronger but showed no significant difference with control group a week after treatment ceased. | Colom et al., 2017 |
Prophylactic phage delivery in an osteointegrative hydrogel | Sodium Alginate/nano-hydroxyapatite (nHAP) hydrogel | E. faecalis phages vB_EfaS_LM99 | In vitro and ex vivo | 97% of phage released in 24 h. No difference in phage release observed for nHAP containing hydrogels. | Phage titers in the hydrogel are stable for 7 days | Approximate 2log10 reduction of CFU after coincubation of hydrogels with bacteria. On a chicken femur ex vivo model a 3log10 reduction of CFU was observed after 48 h. | Pennone et al., 2019 |
Phage delivery triggered by bacteria-secreted hyaluronidase | Composite films of agarose and hyaluronan | S. aureus phage ϕK | In vitro | Phage release of 106 PFU/mL in 4 h of coincubation with hyaluronidase | Not assessed | Not assessed | Barros et al., 2020 |
Treatment of osteomyelitis after implant (i.e., screw) removal | Alginate hydrogel | CRISPR-Cas9 modified phage against S. aureus | In vivo | Not assessed | Not assessed | No significant difference between phage loaded alginate and empty alginate on CFU load of a bone defect. CFU reduction (0.55log10) was observed in the soft tissues surrounding the bone defect. | Cobb et al., 2019 |
Clinical trial: treatment of burn wound patients with P. aeruginosa monoinfections. (Phagoburn project) |
Alginate wound dressing soaked in phage cocktail solution | Phage cocktail of 12 P. aeruginosa phages | Clinical trial | Phage release was assessed in vitro. Burst release of phages was observed. Data set was not published or referenced. | Not assessed | Phage loaded wound dressing performed less effectively as standard of care control (sulfadiazine silver cream). Less adverse side effects were observed in patients undergoing phage treatment. | Jault et al., 2019 |
Abbreviations – CFU: Colony forming unit; nHAP: nano-hydroxyapatite; OD600: Optical density at a wavelength of 600 nm; PEI: Poly(ethylenimine); PFU: Plaque forming unit; SGF: Stimulated gastric fluid; SIF: Stimulated intestinal fluid.